Edition:
United Kingdom

People: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

81.59USD
16 Jul 2019
Change (% chg)

$0.63 (+0.78%)
Prev Close
$80.96
Open
$81.36
Day's High
$81.78
Day's Low
$80.89
Volume
2,367,546
Avg. Vol
3,366,739
52-wk High
$87.07
52-wk Low
$62.09

Davis, Robert 

Mr. Robert M. Davis Executive Vice President, Global Services, and Chief Financial Officer of the company since April 2016 prior to this he was Executive Vice President and Chief Financial Officer from April 2014-April 2016 Corporate Vice President and President, Medical Products, Baxter International, Inc. (October 2010-March 2014) Mr. Davis is responsible for the Company’s global financial organization, investor relations, corporate strategy and business development, global facilities, and the Company’s joint venture relationships. Prior to starting his employment with the Company, Mr. Davis served as Corporate Vice President and President, Medical Products of Baxter International, Inc. (“Baxter”), a healthcare company, a position he had held since October 2010. In that position, Mr. Davis was responsible for all aspects of commercial, R&D, quality, regulatory, manufacturing and supply chain functions. Prior to that position, Mr. Davis served as Corporate Vice President and President, Renal Division of Baxter in 2010 and had previously served as Baxter’s Corporate Vice President and Chief Financial Officer from 2006 to 2010.

Basic Compensation

Total Annual Compensation, USD 2,433,700
Restricted Stock Award, USD 2,764,060
Long-Term Incentive Plans, USD --
All Other, USD 1,423,080
Fiscal Year Total, USD 6,620,840

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --